Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage

Blood

Volumn 99, Issue 1, 2002, Pages 300-309

  Stankovic, Tatjana ^b   Stewart, Grant S ^b   Fegan, Christopher ^b   Biggs, Paul ^b   Last, James ^b   Byrd, Philip J ^b   Keenan, Russell D ^b   Moss, Paul A H ^b   Taylor, Alexander M R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; ATAXIA TELANGIECTASIA; B CELL LYMPHOMA; CHROMOSOME BREAKAGE; CHROMOSOME DAMAGE; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DNA STRAND BREAKAGE; FEMALE; GAMMA IRRADIATION; GENE INACTIVATION; GENE MUTATION; GERMINAL CENTER; HUMAN; HUMAN CELL; MALE; MALIGNANT TRANSFORMATION; ONTOGENY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TISSUE INJURY;

EID: 0036096157     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.1.300     Document Type: Article

References (40)

1. Update on the biology of chronic lymphocytic leukaemia
2. Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukaemia
3. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukaemia
4. Mutation drift and repertoire shift in the maturation of the immune response
5. Leukaemia and lymphoma inataxia telangiectasia
6. Ataxia-telangiectasia and the Nijmegen breakage syndrome: Related disorders but genes apart
7. Clustering of missense mutations in the ataxia telangiectasia gene in a sporadic T cell leukaemia
8. Biallelic mutations in the ATM gene in T-prolymphocytic leukaemia
9. Inactivation of the ATM gene in T-cell prolymphocytic leukaemia
10. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia
11. p53 dysfunction in B-cell chronic lymphocytic leukaemia: Inactivation of ATM as an alternative to TP53 mutation
12. ATM mutations in B-cell chroniclymphocytic leukemia
13. Somatic ATM mutations indicate a pathogenic role of ATM in B-Cell chronic lymphocytic leukemia
14. National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment
15. ATM mutations and phenotypes in A-T families in the British Isles: Expression of mutant ATM and the risk of leukaemia, lymphoma and breast cancer
16. Restriction endonuclease fingerprinting (REF): A sensitive method for screening mutations in long, contiguous segments of DNA
17. The human immunoglobulin VH repertoire
18. Structure and physical map of 64 variable segments in the 3′0.8 megabase region of the human immunoglobulin heavy chain locus
19. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity
20. Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest
21. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia
22. Characterization of ATM gene mutations in 66 ataxia telangiectasia families
23. hMRE11: Genomic structure and a null mutation identified in a transcript protected from nonsense-mediated mRNA decay
24. Residual ATM protein function in cells from ataxia telangiectasia patients, with 5762 ins 137 and 7271T->G mutations, showing a less severe phenotype
25. Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia
26. Cancer genetics
27. Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia
28. Cancers in 44 families with ataxia telangiectasia
29. Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries
30. Cancer risk in heterozygotes for ataxia-telangiectasia
31. No germline ATM mutation in a series of 16 T-cell prolymphocytic leukemias
32. Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma
33. Intraclonal molecular heterogeneity suggests a hierarchy of pathogenic events in Burkitt's lymphoma
34. p53 expression in B cell chronic lymphocytic leukaemia: A marker of disease progression and poor prognosis
35. p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis
36. Tumors associated with p53 germ line mutations: A synopsis of 91 families
37. Mantle cell lymphoma is characterised by inactivation of the ATM gene
38. Atypical chronic lymphocytic leukaemia with t(11;14)(q13; q32): Karyotype evolution and prolymphocytic transformation
39. t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B cell chronic lymphocytic leukaemia
40. Abnormal rearrangement within theα/δ T-cell receptor locus in lymphomas from ATM-deficient mice